NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · page 24 of 25
NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · slide 24
Pitch deck · executive_summary · summarize · overcrowded density
Slide locked Sign in to view
Slide schematic 9/9
image 1/1 list 6/6 title 2/2
Components 9
illustration bullet bullet bullet bullet bullet bullet action-title headline
Tools 2
Executive summary slide · 90%
list/bullet: DA-1241: Open IND for Treatment of MASH and Type 2 Diabetes; Actively recruiting into a Phase 2a; Completed SAD and MAD studies
Storytelling: audience calibration slide · 70%Aiming to Increase Shareholder Value through Multiple, Near-Term, Value Creating Milestones
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.